2018 Q4 Form 10-Q Financial Statement
#000156459018028636 Filed on November 08, 2018
Income Statement
| Concept | 2018 Q4 | 2018 Q3 | 2017 Q3 |
|---|---|---|---|
| Revenue | $26.84M | $23.56M | $11.81M |
| YoY Change | 105.22% | 99.48% | 318.42% |
| Cost Of Revenue | |||
| YoY Change | |||
| Gross Profit | |||
| YoY Change | |||
| Gross Profit Margin | |||
| Selling, General & Admin | $12.26M | $10.99M | $6.420M |
| YoY Change | 64.12% | 71.18% | 27.89% |
| % of Gross Profit | |||
| Research & Development | $33.25M | $28.81M | $18.43M |
| YoY Change | 71.57% | 56.36% | 8.32% |
| % of Gross Profit | |||
| Depreciation & Amortization | $700.0K | $500.0K | $400.0K |
| YoY Change | 40.0% | 25.0% | 100.0% |
| % of Gross Profit | |||
| Operating Expenses | $47.61M | $39.80M | $24.85M |
| YoY Change | 77.36% | 60.19% | 12.79% |
| Operating Profit | -$16.24M | -$13.04M | |
| YoY Change | 24.6% | ||
| Interest Expense | $1.550M | $3.400M | $680.0K |
| YoY Change | 127.94% | 400.0% | 183.33% |
| % of Operating Profit | |||
| Other Income/Expense, Net | |||
| YoY Change | |||
| Pretax Income | -$19.22M | -$12.84M | -$12.35M |
| YoY Change | 46.83% | 3.97% | -34.89% |
| Income Tax | $0.00 | $0.00 | |
| % Of Pretax Income | |||
| Net Earnings | -$18.66M | -$12.84M | -$12.35M |
| YoY Change | 42.57% | 3.96% | -34.86% |
| Net Earnings / Revenue | -69.55% | -54.51% | -104.59% |
| Basic Earnings Per Share | |||
| Diluted Earnings Per Share | -$182.5K | -$126.2K | -$147.5K |
| COMMON SHARES | |||
| Basic Shares Outstanding | 102.1M | ||
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2018 Q4 | 2018 Q3 | 2017 Q3 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $400.1M | $458.6M | $236.7M |
| YoY Change | 64.46% | 93.73% | 52.62% |
| Cash & Equivalents | $140.4M | $39.30M | $29.89M |
| Short-Term Investments | $259.7M | $419.3M | $206.8M |
| Other Short-Term Assets | $5.300M | $3.400M | $1.700M |
| YoY Change | 253.33% | 100.0% | 13.33% |
| Inventory | |||
| Prepaid Expenses | |||
| Receivables | $4.673M | $5.567M | $3.400M |
| Other Receivables | $300.0K | $700.0K | $500.0K |
| Total Short-Term Assets | $410.5M | $468.2M | $242.3M |
| YoY Change | 65.27% | 93.23% | 62.84% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $78.72M | $50.50M | $8.500M |
| YoY Change | 153.41% | 494.12% | 73.47% |
| Goodwill | $40.04M | $1.585M | |
| YoY Change | 2426.44% | ||
| Intangibles | $54.24M | ||
| YoY Change | |||
| Long-Term Investments | $16.30M | ||
| YoY Change | 71.58% | ||
| Other Assets | $3.364M | $6.379M | $1.000M |
| YoY Change | 184.84% | 537.9% | 400.0% |
| Total Long-Term Assets | $179.9M | $138.4M | $27.50M |
| YoY Change | 369.14% | 403.27% | 69.75% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $410.5M | $468.2M | $242.3M |
| Total Long-Term Assets | $179.9M | $138.4M | $27.50M |
| Total Assets | $590.4M | $606.6M | $269.8M |
| YoY Change | 105.9% | 124.83% | 63.52% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $3.355M | $16.40M | $10.10M |
| YoY Change | 20868.75% | 62.38% | 60.32% |
| Accrued Expenses | $9.500M | $6.600M | $4.500M |
| YoY Change | 72.73% | 46.67% | 60.71% |
| Deferred Revenue | $47.56M | $51.09M | |
| YoY Change | 67.8% | ||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | |||
| YoY Change | |||
| Total Short-Term Liabilities | $78.51M | $74.10M | $42.90M |
| YoY Change | 75.02% | 72.73% | 208.63% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | $0.00 | $3.900M |
| YoY Change | -100.0% | -100.0% | 69.57% |
| Other Long-Term Liabilities | $1.960M | $1.730M | $36.30M |
| YoY Change | -93.29% | -95.23% | 626.0% |
| Total Long-Term Liabilities | $1.960M | $1.730M | $40.20M |
| YoY Change | -96.36% | -95.7% | 450.68% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $78.51M | $74.10M | $42.90M |
| Total Long-Term Liabilities | $1.960M | $1.730M | $40.20M |
| Total Liabilities | $223.1M | $226.7M | $83.10M |
| YoY Change | 125.75% | 172.8% | 293.84% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$562.7M | ||
| YoY Change | 13.57% | ||
| Common Stock | $930.7M | ||
| YoY Change | 36.13% | ||
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $366.5M | $379.9M | $186.7M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $590.4M | $606.6M | $269.8M |
| YoY Change | 105.9% | 124.84% | 63.51% |
Cashflow Statement
| Concept | 2018 Q4 | 2018 Q3 | 2017 Q3 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$18.66M | -$12.84M | -$12.35M |
| YoY Change | 42.57% | 3.96% | -34.86% |
| Depreciation, Depletion And Amortization | $700.0K | $500.0K | $400.0K |
| YoY Change | 40.0% | 25.0% | 100.0% |
| Cash From Operating Activities | -$39.50M | -$27.60M | -$15.70M |
| YoY Change | 135.12% | 75.8% | -10.8% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | -$28.10M | -$9.200M | -$700.0K |
| YoY Change | 3022.22% | 1214.29% | 600.0% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $90.90M | $92.00M | -$26.40M |
| YoY Change | 215.63% | -448.48% | -181.99% |
| Cash From Investing Activities | $62.80M | $82.80M | -$27.10M |
| YoY Change | 124.29% | -405.54% | -184.42% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 1.600M | 1.100M | 2.800M |
| YoY Change | -86.99% | -60.71% | 366.67% |
| NET CHANGE | |||
| Cash From Operating Activities | -39.50M | -27.60M | -15.70M |
| Cash From Investing Activities | 62.80M | 82.80M | -27.10M |
| Cash From Financing Activities | 1.600M | 1.100M | 2.800M |
| Net Change In Cash | 24.90M | 56.30M | -40.00M |
| YoY Change | 5.96% | -240.75% | -364.9% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$39.50M | -$27.60M | -$15.70M |
| Capital Expenditures | -$28.10M | -$9.200M | -$700.0K |
| Free Cash Flow | -$11.40M | -$18.40M | -$15.00M |
| YoY Change | -28.3% | 22.67% | -14.29% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2017Q4 | us-gaap |
Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
|
193482000 | |
| CY2017Q4 | us-gaap |
Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
|
1012000 | |
| CY2018Q3 | us-gaap |
Restricted Cash Noncurrent
RestrictedCashNoncurrent
|
79941000 | |
| CY2017Q4 | us-gaap |
Restricted Cash Noncurrent
RestrictedCashNoncurrent
|
3500000 | |
| CY2017Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
24847000 | |
| CY2018Q3 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
51094000 | |
| CY2017Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
28345000 | |
| CY2018Q3 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
123917000 | |
| CY2017Q4 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
29244000 | |
| us-gaap |
Operating Expenses
OperatingExpenses
|
66085000 | ||
| CY2018Q3 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
1730000 | |
| CY2017Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-495479000 | |
| CY2018Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
23562000 | |
| CY2017Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
11812000 | |
| us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
57615000 | ||
| us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
23490000 | ||
| CY2017Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-13035000 | |
| us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-56378000 | ||
| us-gaap |
Profit Loss
ProfitLoss
|
-49670000 | ||
| us-gaap |
Profit Loss
ProfitLoss
|
-41477000 | ||
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
6969000 | ||
| us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-715000 | ||
| us-gaap |
Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
|
259000 | ||
| us-gaap |
Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
|
71000 | ||
| CY2018Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
39298000 | |
| CY2017Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
682809000 | |
| CY2017Q4 | us-gaap |
Liabilities
Liabilities
|
98841000 | |
| CY2017Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2017Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
856000 | |
| dei |
Entity Small Business
EntitySmallBusiness
|
false | ||
| dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | ||
| CY2018Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
102092863 | |
| CY2017Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
49826000 | |
| CY2018Q3 | us-gaap |
Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
|
419272000 | |
| CY2018Q3 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
5567000 | |
| CY2018Q3 | us-gaap |
Interest Receivable Current
InterestReceivableCurrent
|
683000 | |
| CY2018Q3 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
6379000 | |
| CY2017Q4 | us-gaap |
Interest Receivable Current
InterestReceivableCurrent
|
240000 | |
| CY2017Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
3343000 | |
| CY2018Q3 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
3382000 | |
| CY2017Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
1506000 | |
| us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
1030000 | ||
| us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
4043000 | ||
| us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
310000 | ||
| us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-41608000 | ||
| us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
1668000 | ||
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
10374000 | ||
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-41477000 | ||
| CY2018Q3 | us-gaap |
Goodwill
Goodwill
|
1585000 | |
| CY2017Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-286000 | |
| us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
81612000 | ||
| us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
46351000 | ||
| us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-42595000 | ||
| CY2017Q3 | us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
681000 | |
| us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
6708000 | ||
| us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
1118000 | ||
| CY2017Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
18425000 | |
| CY2017Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
6422000 | |
| us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
32381000 | ||
| us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
19734000 | ||
| CY2018Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-16241000 | |
| CY2018Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
39803000 | |
| us-gaap |
Operating Expenses
OperatingExpenses
|
113993000 | ||
| CY2018Q3 | us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
3398000 | |
| CY2018Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
10993000 | |
| us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
743000 | ||
| us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
3676000 | ||
| us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
1589000 | ||
| us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
451239000 | ||
| us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
229595000 | ||
| us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
230547000 | ||
| us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
127093000 | ||
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
15028000 | ||
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
2873000 | ||
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
10374000 | ||
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
6969000 | ||
| us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-1539000 | ||
| us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
118540000 | ||
| us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
56078000 | ||
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
76711000 | ||
| us-gaap |
Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
|
1730000 | ||
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
28021000 | ||
| us-gaap |
Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
|
5221000 | ||
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-240941000 | ||
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-105375000 | ||
| sgmo |
Net Proceeds From Issuance Public Offering
NetProceedsFromIssuancePublicOffering
|
215757000 | ||
| us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
83000 | ||
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
230143000 | ||
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
85187000 | ||
| us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
65913000 | ||
| us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
7833000 | ||
| CY2017Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
53326000 | |
| CY2016Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
22061000 | |
| CY2018Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
119239000 | |
| CY2017Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
29894000 | |
| us-gaap |
Use Of Estimates
UseOfEstimates
|
<div> <p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.27%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.17%;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and the accompanying notes. On an ongoing basis, management evaluates its estimates, including critical accounting policies or estimates related to revenue recognition, clinical trial accruals, and stock-based compensation. Estimates are based on historical experience and on various other market specific and other relevant assumptions that the Company believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates.</p></div> | ||
| sgmo |
Cash Equivalent Maturity Period Highly Liquid Investment
CashEquivalentMaturityPeriodHighlyLiquidInvestment
|
three months or less | ||
| CY2017Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
29894000 | |
| CY2018Q3 | us-gaap |
Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
|
79941000 | |
| CY2018Q3 | us-gaap |
Restricted Cash And Cash Equivalents Noncurrent Asset Statement Of Financial Position Extensible List
RestrictedCashAndCashEquivalentsNoncurrentAssetStatementOfFinancialPositionExtensibleList
|
sgmo:RestrictedCashAndOtherNonCurrentAssets | |
| CY2017Q3 | us-gaap |
Restricted Cash And Cash Equivalents Noncurrent Asset Statement Of Financial Position Extensible List
RestrictedCashAndCashEquivalentsNoncurrentAssetStatementOfFinancialPositionExtensibleList
|
sgmo:RestrictedCashAndOtherNonCurrentAssets | |
| CY2018Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
119239000 | |
| CY2017Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
29894000 | |
| CY2018Q3 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
419485000 | |
| CY2017Q4 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
194749000 | |
| CY2018Q3 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
11000 | |
| CY2018Q3 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
224000 | |
| CY2017Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
255000 | |
| CY2018Q3 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
419272000 | |
| CY2017Q4 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
194494000 | |
| CY2018Q3 | sgmo |
Cash Equivalents And Available For Sale Securities Amortized Cost
CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost
|
419503000 | |
| CY2017Q4 | sgmo |
Cash Equivalents And Available For Sale Securities Amortized Cost
CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost
|
223634000 | |
| CY2018Q3 | sgmo |
Cash Equivalents And Available For Sale Securities Gross Unrealized Gain Before Tax
CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax
|
11000 | |
| CY2018Q3 | sgmo |
Cash Equivalents And Available For Sale Securities Gross Unrealized Loss Before Tax
CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax
|
224000 | |
| CY2017Q4 | sgmo |
Cash Equivalents And Available For Sale Securities Gross Unrealized Loss Before Tax
CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax
|
255000 | |
| CY2018Q3 | sgmo |
Cash Equivalents And Available For Sale Securities
CashEquivalentsAndAvailableForSaleSecurities
|
419290000 | |
| CY2017Q4 | sgmo |
Cash Equivalents And Available For Sale Securities
CashEquivalentsAndAvailableForSaleSecurities
|
223379000 | |
| us-gaap |
Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
|
0 | ||
| us-gaap |
Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
|
0 | ||
| CY2018Q3 | sgmo |
Other Than Temporarily Impaired Investment
OtherThanTemporarilyImpairedInvestment
|
0 | |
| CY2017Q3 | sgmo |
Other Than Temporarily Impaired Investment
OtherThanTemporarilyImpairedInvestment
|
0 | |
| sgmo |
Investments Maturity Dates Available For Sale Securities
InvestmentsMaturityDatesAvailableForSaleSecurities
|
P1Y | ||
| CY2014Q1 | sgmo |
Number Of Research Program
NumberOfResearchProgram
|
2 | |
| CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.35 | |
| us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | ||
| sgmo |
Percentage Of Disallowance Of Entertainment Expense
PercentageOfDisallowanceOfEntertainmentExpense
|
1.00 | ||
| CY2018Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
3810000 | |
| CY2017Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
2219000 |
